Coinfusion of mobilized hematopoietic stem cells from an HLA-mismatched third-party donor with umbilical cord blood graft to support engraftment

Journal of Pediatric Hematology/Oncology

Volumn 36, Issue 8, 2014, Pages e518-e523

  Taskinen, Mervi H ^a   Huttunen, Pasi ^a   Niittyvuopio, Riitta ^b   Saarinen Pihkala, Ulla M ^a  

^a UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Chimerism; Engraftment; Haploidentical; Umbilical cord blood transplantation

Indexed keywords

CD34 ANTIGEN; CYCLOSPORIN A; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APHERESIS; ARTICLE; BLOOD DONOR; CHILD; CHIMERA; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; FAMILY STUDY; FEMALE; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; INFANT; INFECTION; LYMPHOCYTE COUNT; MALE; NEUTROPENIA; NEUTROPHIL; RETROSPECTIVE STUDY; RISK ASSESSMENT; STEM CELL MOBILIZATION; ADULT; CYTOLOGY; FETUS BLOOD; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TEST; IMMUNOSUPPRESSIVE TREATMENT; PRESCHOOL CHILD; PROCEDURES; THROMBOCYTE; TRANSPLANTATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; BLOOD PLATELETS; CHILD; CHILD, PRESCHOOL; FEMALE; FETAL BLOOD; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HISTOCOMPATIBILITY TESTING; HUMANS; INFANT; MALE; NEUTROPHILS; RETROSPECTIVE STUDIES; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME;

EID: 84918560865     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0000000000000222     Document Type: Article

References (22)

1. Gluckman E, Broxmeyer HA, Auerbach AD, et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med. 1989;321:1174-1178.
2. Wagner JE, Barker JN, Defor TE, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood. 2002;100:1611-1618.
3. Eapen M, Rubinstein P, Zhang MJ, et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukemia: a comparison study. Lancet. 2007;369:1947-1954.
4. Rocha V, Locatelli F. Searching for alternative donors of haematopoietic stem cell for pediatric patients. Bone Marrow Transplant. 2008;41:207-214.
5. Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med. 1998;339:1565-1577.
6. Rocha V, Labopin M, Sanz G, et al. Acute Leukemia Working Party of European Blood and Marrow Transplant Group. EuroCord-Netcord Registry. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med. 2004;351:2276-2285.
7. + cells from an HLA-haploidentical donor. Exp Hematol. 2003;31:535-544.
8. Fernández MN. Improving the outcome of cord blood transplantation: use of mobilized HSC and other cells from third party donors. Br J Haematol. 2009;147:161-176.
9. Bertaina A, Bernardo ME, Caniglia M, et al. Cord blood transplantation in children with haematological malignancies. Best Pract Res Clin Haemat. 2010;23:189-196.
10. Sebrango A, Vicuna I, De Laiglesia A, et al. Haematopoietic transplants combining a single unrelated cord blood unit with mobilized haematopoietic stem cells from an adult HLAmismatched third party donor. Comparable results to transplants from HLA-identical related donors in adults with acute leukemia and myelodysplastic syndromes. Best Pract Res Clin Haematol. 2010;23:259-274.
11. Gluckman E. History of cord blood transplantation in children. Bone Marrow Transplant. 2009;44:621-626.
12. Rocha V, Gluckman E, Eurocord-Netcord registry and European Blood and Marrow Transplant group. Improving outcomes of cord blood transplantation: HLA-matching, cell dose and other graft- and transplantation-related factors. Br J Haematol. 2009;147:262-274.
13. Barker JN, Weisdorf DJ, Defor TE. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with haematological malignancy. Blood. 2005;105:1343-1347.
14. Rocha V, Crotta A, Ruggeri A, et al. Eurocord Registry. Double cord blood transplantation: extending the use of unrelated umbilical cord blood cells for patients with haematological disease. Best Pract Res Clin Haematol. 2010;23:223-229.
15. Frassoni F, Gualandi F, Podestà M, et al. Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study. Lancet Oncol. 2008;9:831-839.
16. Bernardo ME, Ball LM, Cometa AM, et al. Co-infusion of exvivo expanded, parental MSCs prevent life-threatening acute GvHD, but does not reduce the risk of graft failure in pediatric patients undergoing allogeneic umbilical cord blood transplantation. Bone Marrow Transplant. 2011;46:200-207.
17. Wu KH, Sheu JN, Wu HP, et al. Cotransplantation of umbilical cord-derived mesenchymal stem cells promote hematopoietic engraftment in cord blood transplantation: a pilot study. Transplantation. 2013;95:773-777.
18. Kwon M, Balsalobre P, Serrano D, et al. Single cord blood combined with HLA-mismatched third party donor cells: comparable results to matched unrelated donor transplantation in high-risk patients with hematologic disorders. Biol Blood Marrow Transplant. 2013;19:143-149.
19. Bernardo ME, Cometa AM, Locatelli F. Mesenchymal stromal cells: a novel and effective strategy for facilitating engraftment and accelerating hematopoietic recovery after transplantation? Bone Marrow Transplant. 2012;47:323-329.
20. Eapen M, Klein JP, Sanz GF, et al. Eurocord-European Group for Blood and Marrow Transplantation, Netcord and the Center of International Blood and Marrow Transplant Research. Effect of donor-recipient HLA matching at HLA A, B, C, DRB1 on outcomes after umbilical-cord blood transplantation for leukemia and myelodysplastic syndrome: a retrospective analysis. Lancet. 2011;12:1214-1221.
21. Bautista G, Gabrera JR, Regidor C, et al. Cord blood transplants supported by co-infusion of mobilized hematopoietic stem cells from a third party donor. Bone Marrow Transplant. 2009;43:365-373.
22. Locatelli F, Rocha V, Reed W, et al. Eurocord Transplant Group. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood. 2003;101:2137-2143.